Skip to main content
. 2017 Dec 26;52(4):270–275. doi: 10.5045/br.2017.52.4.270

Fig. 1. Survival curves. (A) The estimated two-year progression-free survival rate was 36.7% and (B) the two-year overall survival rate was 46.6%.

Fig. 1